External contamination of cytotoxic drug vials

Journal of Pharmacy Practice and Research

Volumn 35, Issue 4, 2005, Pages 264-265

  Gilbar, Peter J ^a,b  

^a Society of Hospital Pharmacists of Australia   (Australia)

^b Toowoomba Health Services   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE;

DRUG CONTAMINATION; DRUG MANUFACTURE; DRUG PACKAGING; DRUG SAFETY; DRUG TRANSPORT; EDITORIAL; GLOVE; OCCUPATIONAL HAZARD; PRACTICE GUIDELINE;

EID: 32644442719     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2005.tb00359.x     Document Type: Editorial

References (12)

1. Baker ES, Connor TH. Monitoring occupational exposure to cancer chemotherapy drugs. Am J Health Syst Pharm 1996; 15: 2713-23.
2. The Society of Hospital Pharmacists of Australia. Committee of Specialty Practice in Oncology. SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments. J Pharm Pract Res 2005; 35: 44-52.
3. Falck K, Grohn P, Sorsa M, Vainio H, Helnonen E, Holsti LR. Mutagenicity in urine of nurses handling cytotoxic drugs. Lancet 1979; 1: 1250-1.
4. Connor TH, Anderson RW, Sessink PJM, Broadfield L, Power LA. Surface contamination with antineoplastic agents in six cancer treatment centres in Canada and the United States. Am J Health Syst Pharm 1999; 56: 1427-32.
5. Ros JJW, Simons KA, Verzijl JM, et al. Practical applications of a validated method of analysis for the detection of traces of cyclophosphamide on injection bottles at an oncological outpatients centre. Ziekenhuisfarmacie 1997; 13: 168-71.
6. Delporte JP, Chenoix P, Hubert P. Chemical contamination of the primary packaging of 5-fluorouracil RTU solutions commercially available on the Belgian market. Environ Health Perspect 1999; 5: 119-21.
7. Nygren O, Gustavsson B, Strom L, Friberg A. Cisplatin contamination observed on the outside of drug vials. Ann Occup Hyg 2002; 46: 555-7.
8. Mason HJ, Motion J, Garfitt SJ, Iqbal S, Jones K. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg 2003; 47: 681-5.
9. Favier B, Gilles L, Ardiet C, Latour JF. External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers. J Oncol Pharm Pract 2003; 9: 15-20.
10. Connor TH, Sessink PJM, Harrison B, et al. Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. Am J Health Syst Pharm 2005; 62: 475-84.
11. Schultz H, Bigelow S, Dobish R, Chambers CR. Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective. J Oncol Pharm Pract 2005; 11: 101-9.
12. Power LA. Demand clean vials [editorial]. Am J Health Syst Pharm 2005; 62: 471.